Nuvo Solves Inherent Problems of Access to Quality Pregnancy Care With Advanced FDA-Cleared Pregnancy Monitoring and Management PlatformCompany Will Begin Trading on NASDAQ Under Ticker Symbol NUVO as of Thursday May 2, 2024 TEL AVIV, Israel and LOS ANGELES, May 1, 2024 /PRNewswire/ -- Holdco Nuvo Group D.G Ltd (NASDAQ: NUVO) ('Nuvo'), a pioneer in remote pregnancy monitoring, today announced completion of its business combination with LAMF Global Ventures Corp.

Nuvo通过先进的FDA批准的妊娠监测和管理平台解决了获得优质妊娠护理的固有问题公司将于2024年5月2日星期四在纳斯达克开始交易，股票代码为Nuvo，以色列特拉维夫和洛杉矶，2024年5月1日/PRNewswire/--Holdco Nuvo Group D.G Ltd（纳斯达克：Nuvo）（“Nuvo”），远程妊娠监测的先驱，今天宣布完成与LAMF Global Ventures Corp.的业务合并。

I (NASDAQ: LGVC) (NASDAQ: LGVCU) (NASDAQ: LGVCW) ('LAMF'), a publicly traded special purpose acquisition company and Nuvo Group Ltd. The combined company will retain the Nuvo name, along with its existing management and operational structure. The company's shares will be listed on NASDAQ under a new ticker symbol (NUVO) as of Thursday, May 2, 2024..

I（纳斯达克：LGVC）（纳斯达克：LGVCU）（纳斯达克：LGVCW）（“LAMF”），一家上市的特殊目的收购公司和Nuvo Group Ltd。合并后的公司将保留Nuvo的名称及其现有的管理和运营结构。该公司股票将于2024年5月2日（星期四）在纳斯达克以新的股票代码（NUVO）上市。。

Continue Reading

继续阅读

The INVU™️ advanced pregnancy monitoring and management platform improves efficiency and access to care by enabling clinicians to conduct fetal non-stress tests with patients anywhere.

INVU™️ 高级妊娠监测和管理平台通过使临床医生能够在任何地方对患者进行胎儿无压力测试，提高了效率和获得护理的机会。

Nuvo is addressing health disparities and breaking down barriers to accessing quality pregnancy care with INVU™️, an advanced pregnancy monitoring and management platform. INVU harnesses wearable technology, AI and machine learning to empower patients and healthcare providers with real-time, actionable insights into maternal-fetal health..

Nuvo正在利用INVU™解决健康差距问题，打破获得优质妊娠护理的障碍️, 先进的妊娠监测和管理平台。INVU利用可穿戴技术、人工智能和机器学习，使患者和医疗保健提供者能够实时、可行地了解母婴健康。。

The physician-prescribed, FDA-cleared platform enables clinicians to conduct fetal non-stress tests (NSTs) with patients anywhere, improving accessibility to care, reducing staffing burdens and enhancing the quality and depth of information available for decision-making. The wearable band and mobile app capture maternal and fetal heart rates and uterine activity signals, which are processed in the cloud and transmitted in real-time for clinician interpretation..

医生规定的，FDA批准的平台使临床医生能够在任何地方对患者进行胎儿无压力测试（NST），改善护理的可及性，减轻人员负担，提高可用于决策的信息的质量和深度。可穿戴频段和移动应用程序可捕获孕妇和胎儿的心率以及子宫活动信号，这些信号在云中进行处理并实时传输以供临床医生解释。。

The combined company will be led by Nuvo's chief executive officer Rice Powell, a 40-year industry veteran with a proven record for meeting consumer health needs while satisfying payor and provider requirements. Rice is the former CEO and Chairman of the Management Board of Fresenius Medical Care, a dual listed company on the Frankfurt and New York stock exchanges, and a leading global provider of kidney dialysis products and services.

合并后的公司将由Nuvo首席执行官赖斯·鲍威尔（RicePowell）领导，他拥有40年的行业经验，在满足消费者健康需求的同时满足支付者和提供者的要求。赖斯是费森尤斯医疗保健公司（Fresenius Medical Care）前首席执行官兼董事会主席，费森尤斯医疗保健公司是法兰克福和纽约证券交易所的双重上市公司，也是全球领先的肾脏透析产品和服务提供商。

He has held several senior leadership positions at Fresenius Medical Care, as well as senior positions at Biogen Inc. and Baxter International Inc. Rice was appointed to Nuvo's Board of Directors in September 2023.'Nuvo is committed to solving the inherent problems of a broken pregnancy care system by enabling access to quality care with advanced remote monitoring technology,' said Rice Powell, CEO of Nuvo.

他曾在费森尤斯医疗保健公司（Fresenius Medical Care）担任多个高级领导职位，并在Biogen Inc.和巴克斯特国际公司（Baxter International Inc.）担任高级职位。赖斯于2023年9月被任命为Nuvo董事会成员。Nuvo首席执行官赖斯·鲍威尔（Rice Powell）说：“Nuvo致力于通过先进的远程监控技术获得优质护理，解决怀孕护理系统崩溃的固有问题。”。

'Becoming a public company provides us with the resources to redefine pregnancy care and address health disparities by ensuring that all expectant mothers can receive timely and accurate care, regardless of their background or location.'The business combination, which was approved at a special meeting of LAMF's shareholders, held on April 1, 2024 and at an extraordinary general meeting of Nuvo shareholders on March 1, 2024, will enable Nuvo to access capital markets to fuel commercial growth, international expansion, and expedite its innovation pipeline.Nuvo was represented on the business combination by Greenberg Traurig and Meitar, and LAMF was represented by White & Case and Herzog Fox & Neeman.About NuvoNuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically-necessary remote pregnancy monitoring anytime, anywhere.

“成为上市公司为我们提供了重新定义孕期保健和解决健康差距的资源，确保所有孕妇无论其背景或地点如何，都能得到及时准确的护理。”该企业合并于2024年4月1日举行的LAMF股东特别会议和2024年3月1日举行的Nuvo股东特别大会上获得批准，将使Nuvo能够进入资本市场，推动商业增长、国际扩张，并加快其创新渠道。Nuvo由Greenberg Traurig和Meitar代表企业合并，LAMF由White＆Case和Herzog Fox＆Neeman代表。关于NuvoNuvo，通过随时随地为临床医生和孕妇提供医学上必要的远程妊娠监测，正在引领妊娠护理的变革。

Nuvo's INVU™ platform is an FDA-cleared remote pregna.

Nuvo的INVU™平台是FDA批准的远程pregna。